Richard Melton

698 total citations
15 papers, 510 citations indexed

About

Richard Melton is a scholar working on Cancer Research, Molecular Biology and Rheumatology. According to data from OpenAlex, Richard Melton has authored 15 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 5 papers in Molecular Biology and 4 papers in Rheumatology. Recurrent topics in Richard Melton's work include Protease and Inhibitor Mechanisms (7 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Chemical Synthesis and Analysis (3 papers). Richard Melton is often cited by papers focused on Protease and Inhibitor Mechanisms (7 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Chemical Synthesis and Analysis (3 papers). Richard Melton collaborates with scholars based in United States, Switzerland and Sweden. Richard Melton's co-authors include Vishwas Ganu, E. F. Miller, Shou‐Ih Hu, John Doughty, V. Blancuzzi, Lijuan Zhu, Brian J. Carroll, Erol K. Bayburt, Elizabeth O’Byrne and David T. Parker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Richard Melton

15 papers receiving 471 citations

Peers

Richard Melton

ONCOL

RHEUM

Rose M. Cubbon United States

Kouhei Sakurai Japan

Gretchen A. Repasky United States

Ignazia Tusa Italy

Eleni Venetsanakos United States

Monzur Rahman United States

Roland P. Bourette France

Winnie F. Tam United States

Sandeep Nambiar Germany

Alf Spitschak Germany

Rose M. Cubbon United States

Richard Melton

69 ×0.2

148 ×0.6

ONCOL

254 ×1.1

38 ×0.5

RHEUM

45 ×0.8

Citations per year, relative to Richard Melton Richard Melton (= 1×) peers Rose M. Cubbon

Countries citing papers authored by Richard Melton

Since Specialization

Citations

This map shows the geographic impact of Richard Melton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Melton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Melton more than expected).

Fields of papers citing papers by Richard Melton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Melton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Melton. The network helps show where Richard Melton may publish in the future.

Co-authorship network of co-authors of Richard Melton

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Melton. A scholar is included among the top collaborators of Richard Melton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Melton. Richard Melton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zhang, Xiaolu, Nina C. Gonnella, James A. Koehn, et al.. (2000). Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1 1 1Edited by P. E. Wright. Journal of Molecular Biology. 301(2). 513–524. 30 indexed citations

Fink, Cynthia A., Ying Qiao, John Doughty, et al.. (1999). Design and synthesis of thiol containing inhibitors of matrix metalloproteinases. Bioorganic & Medicinal Chemistry Letters. 9(2). 195–200. 5 indexed citations

Ganu, Vishwas, et al.. (1999). Matrix Metalloproteinase Inhibitor CGS 27023A Protects COMP and Proteoglycan in the Bovine Articular Cartilage but not the Release of Their Fragments from Cartilage after Prolonged Stimulation in Vitro with IL‐1α. Annals of the New York Academy of Sciences. 878(1). 607–611. 6 indexed citations

Zhang, Xiaolu, et al.. (1998). Solution Structure of the Catalytic Domain of Human Stromelysin-1 Complexed to a Potent, Nonpeptidic Inhibitor. Biochemistry. 37(40). 14048–14056. 22 indexed citations

Ganu, Vishwas, Ronald Goldberg, Jane Peppard, et al.. (1998). Inhibition of interleukin-1?-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: Potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid. Arthritis & Rheumatism. 41(12). 2143–2151. 45 indexed citations

MacPherson, Lawrence, Erol K. Bayburt, Michael Capparelli, et al.. (1997). Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in Rabbits. Journal of Medicinal Chemistry. 40(16). 2525–2532. 288 indexed citations

Goldberg, Ronald, David Parker, Lawrence MacPherson, et al.. (1995). Intra-articular injection of stromelysin into rabbit knees as a model to evaluate matrix metalloprotease inhibitors. Inflammation Research. 44(S2). S115–S116. 4 indexed citations

Ganu, Vishwas, et al.. (1995). Biochemical and molecular characterization of stromelysin synthesized by human osteoarthritic chondrocytes stimulated with recombinant human interleukin-1.. PubMed. 12(5). 489–96. 23 indexed citations

Gonnella, Nina C., Regine S. Bohacek, István Kolossváry, et al.. (1995). Bioactive conformation of stromelysin inhibitors determined by transferred nuclear Overhauser effects.. Proceedings of the National Academy of Sciences. 92(2). 462–466. 12 indexed citations

10.

Doughty, John, Ronald Goldberg, Vishwas Ganu, et al.. (1993). A stromelysin assay for the assessment of metalloprotease inhibitors on human aggregated proteoglycan. Inflammation Research. 39(S1). C151–C153. 5 indexed citations

11.

Ganu, Vishwas, Ronald Goldberg, V. Blancuzzi, et al.. (1991). Elevation of synovial plasminogen activator activity after injection of interleukin-1α into rabbit knee joint. Inflammation Research. 34(1-2). 226–228. 3 indexed citations

12.

Schlesinger, David H., Alan H. Cochrane, Robert W. Gwadz, et al.. (1984). Structure of an immunodominant epitope of the circumsporozoite surface protein of Plasmodium knowlesi. Biochemistry. 23(23). 5665–5670. 18 indexed citations

13.

Melton, Richard, et al.. (1976). A laboratory for the development and evaluation of BMD software quality enhancement techniques. International Conference on Software Engineering. 106–109. 4 indexed citations

14.

Miller, E. F. & Richard Melton. (1975). Automated generation of testcase datasets. ACM SIGPLAN Notices. 10(6). 51–58. 27 indexed citations

15.

Miller, E. F. & Richard Melton. (1975). Automated generation of testcase datasets. 51–58. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact